3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NIH
3
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Prostatic Neoplasms
6
Breast Neoplasms
4
Thyroid Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Carcinoma, Hepatocellular
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Thoracic Diseases
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Seroma
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Recurrence
1
Polycystic Ovary Syndrome
1
Parathyroid Neoplasms
1
Parathyroid Diseases
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Infertility
1
Interventions
Cisplatin
101
Radiotherapy
53
Brachytherapy
41
Paclitaxel
37
Carboplatin
36
Surveys and Questionnaires
28
Blood Specimen Collection
20
pembrolizumab
19
Radiation
17
Magnetic Resonance Spectroscopy
17
Drug Therapy
17
Colposcopy
16
Methods
14
Bevacizumab
14
Early Intervention, Educational
12
toripalimab
11
Topotecan
11
Radiotherapy, Intensity-Modulated
11
Papanicolaou Test
11
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
11
Chemoradiotherapy
11
Biopsy
11
camrelizumab
10
Mass Screening
10
Gemcitabine
10
Patient Navigation
9
Papillomavirus Vaccines
9
Nivolumab
9
Fluorodeoxyglucose F18
9
Educational Status
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Neoplasms
×
Congresses as Topic
×
Clear all
NCT07398313
2026-02-09
PROP-CC
Saveetha University
Phase NA
Completed
34 enrolled